Clinical Trial Update: Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on Phase 1/2 studies testing two doses of PRS CK STORM to calm cytokine storms in ARDS caused by SARS-CoV-2, influenza A/B, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Syncytial Virus Infection

Drugs mentioned

• PRS CK STORM

Snippet

Sponsor: PEACHES BIOTECH | Conditions: SARS-CoV-2, Influenza, Human | Phase 1, Phase 2 | Status: RECRUITING